CONSTELLIUM SE
For the period ended Jun 30, 2026. Filed Jul 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Jul 29, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-03-31; filed 2026-04-29.
0001563411-26-000155
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresCurrent report: 10-Q
Period ended 2026-06-30; filed 2026-07-29.
0001563411-26-000192
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 22 previous paragraphs and 18 current paragraphs.
9 unchanged; 7 reworded; 1 added; 4 removed; 2 previous and 1 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
There have been no material changes to the risk factors disclosed in Item 1A. of our Annual Report on Form 10-K for the
Added paragraphs (1)
Current report
expire on December 31, 2026, of which$72 million remained.
Removed paragraphs (4)
Previous report
program of up to $300 million of the Company’s outstanding shares of ordinary shares, expiring on December 31, 2026.
Previous report
inception of the share repurchase program up to March 31, 2026, approximately 14.7 million shares have been repurchased
Previous report
under the plan for approximately$221 million. In thefirst quarter of 2026, approximately 1.2 million shares were repurchased
Previous report
shareholder approvals at the Company’s 2026 Annual General Meeting of Shareholders to be held on May 21, 2026, and which
Reworded paragraphs (7)
Previous wording
On March 12, 2026, the Company announced that the Board of Directors authorized a new share repurchase program of
Current wording
(1)On March 12, 2026, the Company announced that the Board of Directors authorized a new share repurchase program of up to
Previous wording
up to $300 million of the Company’s outstanding ordinary shares, which will be effective following receipt of the necessary
Current wording
$300 million of the Company’s outstanding ordinary shares, which is effective as of the Company’s 2026 Annual General Meeting of
Previous wording
will expire on December 31, 2028. The new share repurchase program will replace the current share repurchase program
Current wording
Shareholders held on May 21, 2026, and which will expire on December 31, 2028. The new share repurchase program replaces and
Previous wording
authorized by the Board of Directors on February 21, 2024.
Current wording
supersedes the previous share repurchase program authorized by the Board of Directors on February 21, 2024 and which was set to
Previous wording
At March 31, 2026, approximately$79 million was remaining under the Company’s share repurchase program. Since the
Current wording
(2)At June 30, 2026, approximately$287 million remains under the Company’s current share repurchase program. More information
Previous wording
under the plan for approximately$28 million. More information about our share repurchase program is available in Part II, Item
Current wording
about our share repurchase program is available in Part II, Item 5. “Market for Registrant’s Common Equity, Related Stockholder
Previous wording
of Equity Securities by the Issuer and Affiliated Purchasers” of our Annual Report on Form 10-K for the year ended December
Current wording
Annual Report on Form 10-K for the year ended December 31, 2025.
Rearranged current paragraphs (1)
Current report — wording carried from elsewhere
Matters and Issuer Purchases of Equity Securities - Purchases of Equity Securities by the Issuer and Affiliated Purchasers” of our
Rearranged previous paragraphs (2)
Previous report — wording carried elsewhere
On February 21, 2024, the Company announced that the Board of Directors authorized a three-year share repurchase
Previous report — wording carried elsewhere
“Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities - Purchases